Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MLXIPL anticorps (AA 800-852)

MLXIPL Reactivité: Humain, Rat, Souris WB, IF, ChIP Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN540821
  • Antigène Voir toutes MLXIPL Anticorps
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Épitope
    • 15
    • 14
    • 7
    • 6
    • 6
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 800-852
    Reactivité
    • 44
    • 24
    • 14
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Humain, Rat, Souris
    Hôte
    • 56
    • 3
    Lapin
    Clonalité
    • 56
    • 3
    Polyclonal
    Conjugué
    • 26
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MLXIPL est non-conjugé
    Application
    • 35
    • 20
    • 20
    • 13
    • 13
    • 10
    • 9
    • 9
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Chromatin Immunoprecipitation (ChIP)
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of MLXIPL.
    Specificité
    This antibody is specific to ChREBP.
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Antibody Reactive Against Synthetic Peptide.
    Immunogène
    A synthetic peptide corresponding to amino acids 800-852 of human MLXIPL.
    Top Product
    Discover our top product MLXIPL Anticorps primaire
  • Indications d'application
    Immunofluorescence (1:100-1:500)
    Western Blot (1:1000)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.01 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store at 4°C. Do not freeze.
  • Moon, Hammer, Horton: "Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice." dans: Journal of lipid research, Vol. 50, Issue 3, pp. 412-23, (2009) (PubMed).

    Aneja, Guha, Shilpi, Chakraborty, Schramm, Haldar: "The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase." dans: Archives of biochemistry and biophysics, Vol. 470, Issue 1, pp. 35-43, (2008) (PubMed).

    Wang, Torres-Gonzalez, Tripathy, Botolin, Christian, Jump: "Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition." dans: Journal of lipid research, Vol. 49, Issue 7, pp. 1538-52, (2008) (PubMed).

    Erhuma, Salter, Sculley, Langley-Evans, Bennett: "Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat." dans: American journal of physiology. Endocrinology and metabolism, Vol. 292, Issue 6, pp. E1702-14, (2007) (PubMed).

  • Antigène
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Autre désignation
    MLXIPL (MLXIPL Produits)
    Synonymes
    anticorps ChREBP, anticorps MLXIPL, anticorps CHREBP, anticorps MIO, anticorps MONDOB, anticorps WBSCR14, anticorps WS-bHLH, anticorps bHLHd14, anticorps Wbscr14, anticorps MLX interacting protein-like, anticorps MLX interacting protein like, anticorps MLXIPL, anticorps Mlxipl
    ID gène
    51085
    Pathways
    Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Vous êtes ici:
Support technique